Chamber colleagues Kate Sullivan, Vice President of Business Investment and Regional Marketing, and Bryan Tsao, Ph.D., Manager, Life Sciences and Healthcare Initiatives, boosted our market as a leading center for life sciences and a top cell and gene therapy, gene editing, and connected health technology hub at 2023 BIO International Convention (BIO 2023), held in Boston earlier this month.
In addition to bringing Greater Philadelphia’s story to the business development executives, investors, research analysts, and media in attendance, the Chamber team sat down with more than 30 companies, many of them international, to discuss the benefits of doing business in our region. They connected with representatives from organizations in Australia, Brazil, Japan, the Netherlands, Spain, Sweden, Switzerland, and the United Kingdom. Conversations centered on location opportunities, collaborators, and clinical trials in our region.
The Pennsylvania Department of Community and Economic Development, City of Philadelphia Department of Commerce, Life Sciences PA, and PHL Life Sciences (a branch of the Philadelphia Convention and Visitors Bureau, or PHLCVB) utilized the Pennsylvania Partners Pavilion – and a branded charging station (pictured above) – to share information about the region’s talent, innovation, life sciences ecosystem, and business attraction initiatives.
BIO 2023, organized by the Biotechnology Innovation Organization, the world’s largest trade association representing biotechnology companies, academic institutions, state biotechnology centers, and related organizations, is the industry’s largest gathering of its kind. Approximately 20,000 people attended this year.
It was at the 2019 BIO International Convention, proudly hosted in Philadelphia, that the Chamber and its partners announced the Cell & Gene Therapy and Connected Health Initiative.
The Chamber’s business attraction team will join BIO 2024 in San Diego. The BIO International Convention returns to Philadelphia in 2027.